Market Cap 62.17M
Revenue (ttm) 0.00
Net Income (ttm) -25.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 16.96
Profit Margin 0.00%
Debt to Equity Ratio -0.39
Volume 610,800
Avg Vol 1,007,316
Day's Range N/A - N/A
Shares Out 29.61M
Stochastic %K 12%
Beta 1.62
Analysts Sell
Price Target $36.75

Company Profile

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-f...

Industry: Biotechnology
Sector: Healthcare
Phone: 484 254 6134
Address:
1201 Orange Street, Suite 600, Wilmington, United States
NVDAMillionaire
NVDAMillionaire Feb. 4 at 7:44 AM
$NRXP Brilliant piece that captures NRXP's situation perfectly. So if you want to update your understanding of NRXP or get to know NRXP better, this is essential reading. https://everyticker.com/quote/NRXP/analysis/nrxp-s-bridge-to-profitability-can-a-pre-revenue-biotech-build-a-psychiatry-clinic-chain-while-its-ketamine-franchise-takes-shape-nasdaq-nrxp
0 · Reply
Tedhh
Tedhh Feb. 4 at 5:40 AM
$NRXP 1.99?? Wtf
0 · Reply
systemish
systemish Feb. 3 at 8:17 PM
$NRXP WTF we doing here? Sort the data. File the NDA. PR the submission. Nothing else matters. Just get it done.
0 · Reply
Davidh1234
Davidh1234 Feb. 3 at 7:38 PM
$NRXP At least the new COO is not a relative of the CEO. Maybe we have a chance?
0 · Reply
jonny80s
jonny80s Feb. 3 at 6:40 PM
$NRXP anyone a little concerned about the +2mil shares that disappeared into the ether a little over a month ago…. Anson was apparently paid with them, but they are just gone. Someone sure has been shorting the hell out of this for the past 2 months????? To the tune of 2mil shares. So strange?!?!
1 · Reply
Im_Trying
Im_Trying Feb. 3 at 6:18 PM
$NRXP this company is dead. a shell. there was never anything here except for a series of lies and a piggy bank for Javitt the conman.
1 · Reply
Trending__Now
Trending__Now Feb. 3 at 5:37 PM
$NRXP It's all controlled. Static. Eventually "they'll" have to make their move. HOPE clinics should firm up. The positives of like minded greed standardizing mental health. Stating the obvious, it now comes down to FDA approval and the Trumps administration desire for standardized low cost FDA approved therapies. Zacks recently stated a strong sell. The realty is this company isn't worth $0.50 on paper. Sometime in July but hopefully before, and if this management has their stuff in order insurance approval should only take around 60 days. 90 days later we'll see the evidence. That brings us into December. We're not the first to market, thats already been done, but that should allow us to scale much faster with HOPE and the other neurocare centers. Crystal ball is a little hazy but maybe $30+ million this year? Potential buyout next 5-7 years IMO. Has real potential, but...
1 · Reply
dontfeedthebashers
dontfeedthebashers Feb. 3 at 3:31 PM
1 · Reply
Outcomes
Outcomes Feb. 3 at 12:19 PM
$NRXP https://www.youtube.com/watch?v=zDs0lrsJ_G0
0 · Reply
the_franz
the_franz Feb. 3 at 12:02 PM
$NRXP I really wonder why they need a COO. It's not as if the CEO is too busy, since he still has time to run a restaurant. At a company I would trust, I would say that at the early stage the company is in, this is a good indicator of the tasks that lie ahead. With this company... well... I'm asking myself if the COO still has enough drive to bring NRx forward. In any case, I'm closely monitoring EDGAR to see some Form 4s. It's about time (i.e. 2.5 years) that someone invests his own money into this company to show some trust.
2 · Reply
Latest News on NRXP
NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript

Nov 17, 2025, 11:57 AM EST - 2 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript


NRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call Transcript

Aug 20, 2025, 12:23 PM EDT - 5 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call Transcript


NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript

Mar 17, 2025, 10:50 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript


NVDAMillionaire
NVDAMillionaire Feb. 4 at 7:44 AM
$NRXP Brilliant piece that captures NRXP's situation perfectly. So if you want to update your understanding of NRXP or get to know NRXP better, this is essential reading. https://everyticker.com/quote/NRXP/analysis/nrxp-s-bridge-to-profitability-can-a-pre-revenue-biotech-build-a-psychiatry-clinic-chain-while-its-ketamine-franchise-takes-shape-nasdaq-nrxp
0 · Reply
Tedhh
Tedhh Feb. 4 at 5:40 AM
$NRXP 1.99?? Wtf
0 · Reply
systemish
systemish Feb. 3 at 8:17 PM
$NRXP WTF we doing here? Sort the data. File the NDA. PR the submission. Nothing else matters. Just get it done.
0 · Reply
Davidh1234
Davidh1234 Feb. 3 at 7:38 PM
$NRXP At least the new COO is not a relative of the CEO. Maybe we have a chance?
0 · Reply
jonny80s
jonny80s Feb. 3 at 6:40 PM
$NRXP anyone a little concerned about the +2mil shares that disappeared into the ether a little over a month ago…. Anson was apparently paid with them, but they are just gone. Someone sure has been shorting the hell out of this for the past 2 months????? To the tune of 2mil shares. So strange?!?!
1 · Reply
Im_Trying
Im_Trying Feb. 3 at 6:18 PM
$NRXP this company is dead. a shell. there was never anything here except for a series of lies and a piggy bank for Javitt the conman.
1 · Reply
Trending__Now
Trending__Now Feb. 3 at 5:37 PM
$NRXP It's all controlled. Static. Eventually "they'll" have to make their move. HOPE clinics should firm up. The positives of like minded greed standardizing mental health. Stating the obvious, it now comes down to FDA approval and the Trumps administration desire for standardized low cost FDA approved therapies. Zacks recently stated a strong sell. The realty is this company isn't worth $0.50 on paper. Sometime in July but hopefully before, and if this management has their stuff in order insurance approval should only take around 60 days. 90 days later we'll see the evidence. That brings us into December. We're not the first to market, thats already been done, but that should allow us to scale much faster with HOPE and the other neurocare centers. Crystal ball is a little hazy but maybe $30+ million this year? Potential buyout next 5-7 years IMO. Has real potential, but...
1 · Reply
dontfeedthebashers
dontfeedthebashers Feb. 3 at 3:31 PM
1 · Reply
Outcomes
Outcomes Feb. 3 at 12:19 PM
$NRXP https://www.youtube.com/watch?v=zDs0lrsJ_G0
0 · Reply
the_franz
the_franz Feb. 3 at 12:02 PM
$NRXP I really wonder why they need a COO. It's not as if the CEO is too busy, since he still has time to run a restaurant. At a company I would trust, I would say that at the early stage the company is in, this is a good indicator of the tasks that lie ahead. With this company... well... I'm asking myself if the COO still has enough drive to bring NRx forward. In any case, I'm closely monitoring EDGAR to see some Form 4s. It's about time (i.e. 2.5 years) that someone invests his own money into this company to show some trust.
2 · Reply
jckdg
jckdg Feb. 3 at 11:05 AM
$NRXP NRXP Borrow Fee (CTB) Latest As of 2026-02-03 05:57:44 AM EST, there were 400,000 shares available with a fee of 4.87%.
0 · Reply
jckdg
jckdg Feb. 3 at 11:04 AM
$NRXP NRXP Short Volume Summary for Feb 2, 2026 Today's Short Volume is 85,427, which is 56.86% of today's total reported volume. Over the past 30 days, the average Short Volume has been 55.30%.
0 · Reply
TradingUK
TradingUK Feb. 3 at 6:38 AM
$NRXP $7.50 or $5CALL options expire June sound good
0 · Reply
BioRich
BioRich Feb. 3 at 12:27 AM
$NRXP Great News and great addition! https://ir.nrxpharma.com/node/10776/html
2 · Reply
Outcomes
Outcomes Feb. 3 at 12:05 AM
0 · Reply
Tedhh
Tedhh Feb. 2 at 10:25 PM
$NRXP On January 27, 2026, the Board of Directors of the Company appointed Joseph M. Casper, age 75, as the Chief Operating Officer of the Company, effective January 27, 2026. Mr. Casper brings 35 years of experience in the healthcare industry to the Company’s leadership team. Prior to joining the Company, Mr. Casper has held various senior leadership positions. Mr. Casper has served in consulting leadership positions with Deloitte and First Consulting Group, where he advised large organizations and academic medical centers. His professional experience also includes work with major payer and provider organizations, including Kaiser Permanente and Anthem. He also worked extensively with academic medical centers such as the University Medical Center, Cleveland, Ohio. Mr. Casper is the co-inventor of an early medical record aggregation platform that ultimately scaled to serve more than 15 million patients.
0 · Reply
Mrweber1234
Mrweber1234 Feb. 2 at 8:31 PM
0 · Reply
Outcomes
Outcomes Feb. 2 at 7:04 PM
$NRXP .....HOPE! https://www.hhs.gov/press-room/secretary-kennedy-announces-100-million-investment-great-american-recovery.html
1 · Reply
WhereDidAllTheMoneyGo
WhereDidAllTheMoneyGo Feb. 2 at 12:35 PM
1 · Reply
jckdg
jckdg Feb. 2 at 10:29 AM
$NRXP NRXP Short Volume Summary for Jan 30, 2026 Today's Short Volume is 104,689, which is 46.96% of today's total reported volume. Over the past 30 days, the average Short Volume has been 55.73%.
0 · Reply
jonny80s
jonny80s Feb. 2 at 4:08 AM
$NRXP anyone expect anything from Javitt this week or is he in hiding till he can’t anymore come end of March?
5 · Reply
the_franz
the_franz Feb. 1 at 7:52 PM
$NRXP Well, the study regarding DCS + TMS is online since November. Is NRX-101 now a DCS-only drug? 🤔 Anyway, pumpers, do better, spread information: https://clinicaltrials.gov/study/NCT07227103 Or don't you spread it because you know about yet another missed deadline regarding the study involving NRX-101 and cUTI? https://clinicaltrials.gov/study/NCT06128213 😉
2 · Reply